AcelRx to Host First Quarter 2023 Financial Results Call and Webcast on May 10, 2023

HAYWARD, Calif., April 27, 2023 /PRNewswire/ — AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that it will release first…